Wordt geladen...
Neurological safety of fingolimod: An updated review
Fingolimod (FTY) is the first oral medication approved for treatment of relapsing–remitting multiple sclerosis (RRMS). Its effectiveness and safety were confirmed in several phase III clinical trials, but proper evaluation of safety in the real patient population requires long‐term post‐marketing mo...
Bewaard in:
| Gepubliceerd in: | Clin Exp Neuroimmunol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5575715/ https://ncbi.nlm.nih.gov/pubmed/28932291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen3.12397 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|